These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2813210)

  • 1. How to manage other risk factors in patients with hypertension.
    Borhani NO
    Postgrad Med; 1989 Nov; 86(6):171-6. PubMed ID: 2813210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and coronary risk: implications of current knowledge.
    Stamler J
    Acta Cardiol; 1974; Suppl 20():119-57. PubMed ID: 4548616
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
    Maxwell MH
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive drug therapy and coronary heart disease risk.
    Schoenberger JA
    J Fam Pract; 1993 Jan; 36(1):70-3, 77-84. PubMed ID: 8419507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study.
    Psaty BM; Furberg CD; Kuller LH; Borhani NO; Rautaharju PM; O'Leary DH; Bild DE; Robbins J; Fried LP; Reid C
    JAMA; 1992 Sep; 268(10):1287-91. PubMed ID: 1387172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of arterial hypertension in diabetic patients. When to start the treatment and which drugs to use?].
    Romanò M; Baldini MR
    Minerva Med; 1992 Nov; 83(11):725-30. PubMed ID: 1361040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk predictors, risk indicators, and benefit factors in hypertension.
    Dollery CT
    Am J Med; 1987 Jan; 82(1A):2-8. PubMed ID: 3799698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary heart disease risk factors and antihypertensive drug selection.
    Kaplan NM
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S187-9. PubMed ID: 6177954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension: goal systolic and diastolic blood pressure.
    Weir MR
    Curr Hypertens Rep; 1999 Oct; 1(5):411-3. PubMed ID: 10981098
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery.
    Aronson S; Boisvert D; Lapp W
    Anesth Analg; 2002 May; 94(5):1079-84, table of contents. PubMed ID: 11973166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The J-curve in arterial hypertension: fact or fallacy?
    Tsika EP; Poulimenos LE; Boudoulas KD; Manolis AJ
    Cardiology; 2014; 129(2):126-35. PubMed ID: 25227573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in hypertension: mild hypertension, isolated systolic hypertension, and the choice of a step one drug.
    Cressman MD; Gifford RW
    Clin Cardiol; 1983 Jan; 6(1):1-10. PubMed ID: 6339130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
    Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; de Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
    JAMA; 2002 Sep; 288(12):1491-8. PubMed ID: 12243636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
    Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualizing drug therapy for the hypertensive patient.
    Bravo EL
    Hosp Pract (Off Ed); 1995 Mar; 30(3):97-101, 105, 108; quiz 94. PubMed ID: 7883815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.